Does LAPATINIB DITOSYLATE Cause Disease progression? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Disease progression have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 3.5% of all adverse event reports for LAPATINIB DITOSYLATE.
137
Reports of Disease progression with LAPATINIB DITOSYLATE
3.5%
of all LAPATINIB DITOSYLATE reports
35
Deaths
22
Hospitalizations
How Dangerous Is Disease progression From LAPATINIB DITOSYLATE?
Of the 137 reports, 35 (25.5%) resulted in death, 22 (16.1%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does LAPATINIB DITOSYLATE Cause?
Diarrhoea (893)
Death (665)
Nausea (317)
Fatigue (301)
Vomiting (259)
Rash (249)
Drug ineffective (183)
Malignant neoplasm progression (183)
Off label use (141)
Palmar-plantar erythrodysaesthesia syndrome (135)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which LAPATINIB DITOSYLATE Alternatives Have Lower Disease progression Risk?
LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
LAPATINIB DITOSYLATE vs LARONIDASE
LAPATINIB DITOSYLATE vs LAROTRECTINIB
LAPATINIB DITOSYLATE vs LASILIX
LAPATINIB DITOSYLATE vs LASIX